openPR Logo
Press release

Rising Prevalence of Neurological Diseases like Traumatic Stroke and Parkinson’s Disease Drives Neuroprosthetics Market

04-25-2017 03:03 PM CET | IT, New Media & Software

Press release from: TMR - Research Reports

Rising Prevalence of Neurological Diseases like Traumatic

Neuroprosthetics, also known as brain implants or neural implants, have added significant momentum in the past few years due to the massive potential to substitute any injured motor, sensory or cognitive functions. Neuroprosthetic devices improve or replace the function of the central nervous system when implanted in the human body and thus stimulate the function of an organ or organ system that has failed due to disease or injury. It is a brain-computer interface device used to detect and translate neural activity into command sequences for prostheses.

Browse the Complete Report Details at: http://www.transparencymarketresearch.com/neuroprosthetics-market.html

The primary function of neuroprosthetics is to restore the functionality in patients suffering from loss of motor control such as amyotrophic lateral sclerosis, multiple sclerosis, spinal cord injury, and stroke. These devices are important to enhance the ‘quality-of-life’ of the affected patient population. Neuroprosthetics, as therapeutic modalities, are emerging as a promising opportunity in cases where all usual treatments fail to deliver results to cure the disease condition.

The global Neuroprosthetics market is segmented on the basis of applications, technology, types and geography.Mechanism of action (MOA) of neuroprosthetics differs as per underlying technologies. Hence on the basis of technology neuroprosthetics market is divided into vagus nerve stimulation (VNS), spinal cord stimulation (SCS), deep brain stimulation (DBS) and sacral nerve stimulation (SCS). Sacral cord stimulation (SCS) is the fastest growing technology segment of neuroprosthetics. Several types of neuroprosthetics have been developed on the basis of application areas. Motor neuroprosthetics help in treatment of motor neuron disorders such as parkinson’s disease, epilepsy, cochlear implants or auditory neuroprosthetics. Retinal implants or visual neuroprosthetics; and cognitive neuroprosthetics help in treatment of alzheimer’s disease, and severe depression and are the fastest growing neuroprosthetics segment, due to increase in growth attribute of improving ‘quality-of-life’ of visually impaired patients. Furthermore, applications such as overactive bladder syndrome, parkinson's disease and epilepsy are expected to contribute largely to the growth of the overall global neuroprosthetics market.

Geographically, the global neuroprosthetics market is segmented into North America, Europe, Asia Pacific and Rest of the World. North America dominates the neuroprosthetics market due to growth in aging population, and increase in incidence of neurological disorders. Asia Pacific region is expected to display a high growth rate in the forecast period in the global neuroprosthetics market. India and China are the fastest growing markets in the Asia-Pacific region due to increasing awareness about the disease, large pool of patients, improving healthcare infrastructure, and expanding government funding in the region.

Rising prevalence of neurological diseases like traumatic stroke and Parkinson’s disease, brain injury, increase in ageing population, growing awareness about health care, rise in health care expenditure, rapid development of technology, and growing number of initiatives by various government associations and governments are some of the major factors driving growth of the global neuroprosthetics market. Factors such as reimbursement issues, high cost of procedures and adverse effects, however, are known to inhibit the growth of the global neuroprosthetics market. Modern self-charging neural implants that reduce the need for high cost surgery and increased risk to substitute the discharge battery and controlling machinery would help to develop opportunities for the growth of the global neuroprosthetics market.

Obtain the Sample Report Containing the Future Analysis for this Market at: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4617

Some of the key global participants present in the neuroprosthetics market include Cochlear Ltd., Boston Scientific Corporation, Cyberonics, Inc., Medtronic plc, NDI Medical LLC, NeuroPace, Inc., St. Jude Medical, Inc., Nervo Corp., Retina Implant AG, Biomet, Inc., and Sonova .

Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Rising Prevalence of Neurological Diseases like Traumatic Stroke and Parkinson’s Disease Drives Neuroprosthetics Market here

News-ID: 514393 • Views:

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2024
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1.07 Billion by 2024
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million by 2024
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases


More Releases for Neuroprosthetic

Neuroprosthetic System Market 2022-2028: Key Players is Seeing Explosive Growth …
Neuroprosthetic System Market research report forecast 2022-2028 has been prepared by experienced and knowledgeable market analysts and researchers. Each section of the research study is specially prepared to explore key aspects of the Industry. Buyers of the report will have access to accurate Porter's 5 Analysis, PESTLE, SWOT, and other types of analysis on the global Neuroprosthetic System market. The report aims to provide a thorough and accurate analysis of
Exclusive Demand Of Neuroprosthetic System Market 2022: Prominent Share, Industr …
The "Neuroprosthetic System Market" research report provides in-depth information on the key players, growth strategies, investors in the market, and more. This Neuroprosthetic System market report presents a professional and in-depth analysis of the current status of market segments including product type, application, capacity, production, market share, price, revenue, growth rate, etc. The study on Global Neuroprosthetic System market dynamics analysis looks critically at business regulatory frameworks, technological advancements, and
Neuroprosthetic System Market Analysis, Status and Business Outlook 2021 to 2027 …
Global Neuroprosthetic System Sales Market Report 2021 The Neuroprosthetic System Market Report 2021-2027 provides global market size, regional and national level market size, market segment growth, market share, competitive landscape, sales analysis, influence of domestic and global market participants, and value chain Detailed analysis of optimization, trade regulations, latest developments, opportunity analysis, strategic market growth analysis, product launches, regional market expansion and technological innovation. Neuroprosthetic System Market refers to the protection of
Global Neuroprosthetic System Market 2020 COVID-19 Situation Analysis | Medtroni …
Global Neuroprosthetic System Market 2020 by Manufacturers, Type and Application, Forecast to 2025 aims to define, describe, and analyse the market share, market competition landscape, SWOT analysis, and development plans in the next few years. The report studies and analyses market size (value & volume) by company, key regions/countries, products and application, history data from 2015 to 2019, and forecast to 2025. The report explains the structure of the global
Global Neuroprosthetic System Market By Type (Output Neural Prosthetics, Input N …
The Global Neuroprosthetic System Market 2020 report implement in-depth research of the industry with a focus on the current market trends future prospects. The Global Neuroprosthetic System Market report aims to provide an overview of Neuroprosthetic System Market players with detailed market segmentation by product, application and geographical region. It also provides market share and size, revenue forecast, growth opportunity. The most recent trending report Worldwide Neuroprosthetic System Market Economy
Neuroprosthetic System Market Trends, Drivers, Strategies, Segmentation Applicat …
Neuroprosthetic System Market Research Report gives complete information of industry competitors, product categories, applications. The main aim of this report is to provide in-depth analysis of Market Size (Sales) Comparison by Type, End Users and Regions. This report focuses on top Manufactures in North America, Europe, Asia-Pacific, South America, and Middle East & Africa. The stakeholders covered in Neuroprosthetic System Market report are Manufacturers, Distributors/Traders/Wholesalers, Subcomponent Manufacturers, Industry Association and downstream